Targeted Therapeutics Market - Global Industry Analysis

Targeted Therapeutics Market - By Type (Monoclonal Antibodies, Small Molecular Inhibitors, Prodrug, and Nano-Particulate Antibody Conjugates), By Application (Breast Cancer, Leukemia, Colorectal Cancer, Lymphoma, Renal Cancer, Multiple Sclerosis, Wet Age-Related Macular Degeneration, and Lung Cancer), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies),And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Published Date: 10-Aug-2021 Category: Pharmaceutical Report Format : PDF Pages: 100 Report Code: ZMR-6577 Status : Published

The global Targeted Therapeutics market accrued earnings worth approximately 68.1 (USD Billion) in 2020 and is predicted to gain revenue of about 99.3(USD Billion) by 2028, is set to record a CAGR of nearly 12.1% over the period from 2021 to 2028.

Description

The global Targeted Therapeutics market accrued earnings worth approximately 68.1 (USD Billion) in 2020 and is predicted to gain revenue of about 99.3(USD Billion) by 2028, is set to record a CAGR of nearly 12.1% over the period from 2021 to 2028. The report offers assessment and analysis of the Targeted Therapeutics market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Report Scope :

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Targeted Therapeutics Market: Synopsis

Targeted therapeutics is a kind of cancer therapy making use of medicines to target cancer tissues without impacting healthy cells. Moreover, these targeted therapies are used in combination with other medicines or conventional therapies for effectively treating cancer. In recent years, personalized cancer treatment with targeted agents is taking center stage and provides personalized treatment to individuals. Apparently, therapeutic peptides are utilized in biomedical applications and they offer high potential in targeting delivery of medicines owing to its selectivity, biocompatibility, specificity, small dimensions, and modifying ease. Furthermore, in last few years use of tumor targeting peptides as therapeutics have influenced cancer research & nanotechnology domain.  Additionally, targeted therapeutics have also found slew of applications in breast cancer treatment as well as endometrial cancer therapy. Moreover, myriad types of targeted therapeutics are used for cancer treatment and this includes monoclonal antibodies, small molecular inhibitors, prodrug, and nano-particulate antibody conjugates.

Reportedly, first targeted cancer therapeutics was tamoxifen during 1970. Furthermore, U.S. FDA have approved targeted therapies for cancer that include Xgeva, Votrient, Affinitor, Istodax, Tasigna, Sutent, Zolinza, Sprycel, Rituxan, and Herceptin.

Targeted Therapeutics Market: Growth Factors

Growing focus on cancer drug development and cytotoxic & non-specific chemotherapies has shifted to molecularly targeted and rationally developed medicines which has potential of providing more efficiency with lesser side-effects. This, in turn, will prompt growth of targeted therapeutics market in coming decade. Need for developing specific cancer drugs for treating individuals and necessity of comprehensively understanding genetics & biology of patient will drive targeted therapeutics market trends. Apart from this, shift towards integrated cancer research activities and highlight on biomarker-based & hypothesis-driven clinical trials is expected to create new growth avenues for targeted therapeutics market in near future. Additionally, loophole of chemotherapy is drug resistance & severe side effects on patients. Moreover, way to minimize the chemotherapy effects on healthy cancer tissues of patients is to change bio-distribution of medicine and this can be achieved through passive targeting & active targeting of drugs, thereby steering industry landscape.

Furthermore, targeted therapeutics business is gaining significance owing to its specificity towards cancerous tissues while sparing toxicity to normal as well as off-target cell tissues. Comprehensive understanding of molecular activities underlying cancer in human beings and development of new drugs targeting cancerous cells is anticipated to expedite growth of targeted therapeutics industry over upcoming years. Nevertheless, unmet medical needs and lack of reliability of pre-clinical models for predicting efficacy of cancer treating drugs can impede growth of targeted therapeutics market in foreseeable future.

Regional Landscape

Asia Pacific Market To Expand Leaps & Bounds During 2021-2028

Asia Pacific targeted therapeutics market is entering a new era of growth with China possessing huge potential due to success of I-PASS clinical trials on patients in the country. Apart from this, China is slated to play a key role in production of new anti-cancer therapeutic agents, thereby contributing humungously towards regional market size. Furthermore, breakthroughs in pharmacokinetics, cancer biology, and pharmacodynamics along with development of core capabilities in molecular testing of tumor samples will create new growth opportunities for targeted therapeutics market in Asia Pacific.

Competitive Landscape

Key players profiled in study and influencing market growth are Amgen, Inc., Sanofi, AstraZeneca, Roche Diagnostics, Bayer AG,     Novartis AG, Merck & Co., Inc., Seagen, Inc., Pfizer, Inc., Takeda Pharmaceutical Company Limited, and GlaxoSmithKline plc.

The global Targeted Therapeutics Market is segmented as follows:

By Type

  • Monoclonal Antibodies
  • Small Molecular Inhibitors
  • Prodrug
  • Nano-Particulate Antibody Conjugates

By Application

  • Breast Cancer
  • Leukemia
  • Lung Cancer
  • Colorectal Cancer
  • Lymphoma
  • Renal Cancer
  • Multiple Sclerosis
  • Wet Age-Related Macular Degeneration

By Distribution Channel

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Targeted Therapeutics Market, 2018–2028(USD Billion)
    • 2.2. Targeted Therapeutics Market: Snapshot
  • Chapter 3. Global Targeted Therapeutics Market– Application Analysis
    • 3.1. Targeted Therapeutics Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Focus on cancer medicine development and cytotoxic & non-specific chemotherapies have shifted to mulecularly targeted and rationally developed drugs having potential of providing more efficiency with lesser side-effects. This, in turn, will promulgate growth of targeted therapeutics market in upcoming years.
      • 3.2.2. Need for developing specific cancer medicines for treating patients and necessity of comprehensively knowing concepts & ideas related to genetics & biulogy of individual will expedite targeted therapeutics market revenue.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Type
      • 3.4.2. Market attractiveness analysis By Application
      • 3.4.3. Market attractiveness analysis By Distribution Channel
  • Chapter 4. Global Targeted Therapeutics Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Targeted Therapeutics Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Targeted Therapeutics Market– Type Analysis
    • 5.1. Global Targeted Therapeutics Market overview: By Type
      • 5.1.1. Global Targeted Therapeutics Market share, By Type, 2020 and 2028
    • 5.2. Monoclonal Antibodies
      • 5.2.1. Global Targeted Therapeutics Market by Monoclonal Antibodies, 2018–2028(USD Billion)
    • 5.3. Small Mulecular Inhibitors
      • 5.3.1. Global Targeted Therapeutics Market by Small Mulecular Inhibitors, 2018–2028(USD Billion)
    • 5.4. Prodrug
      • 5.4.1. Global Targeted Therapeutics Market by Prodrug, 2018–2028(USD Billion)
    • 5.5. Nano-Particulate Antibody Conjugates
      • 5.5.1. Global Targeted Therapeutics Market by Nano-Particulate Antibody Conjugates, 2018–2028(USD Billion)
  • Chapter 6. Global Targeted Therapeutics Market– Application Analysis
    • 6.1. Global Targeted Therapeutics Market overview: By Application
      • 6.1.1. Global Targeted Therapeutics Market share, By Application, 2020 and 2028
    • 6.2. Breast Cancer
      • 6.2.1. Global Targeted Therapeutics Market by Breast Cancer , 2018–2028(USD Billion)
    • 6.3. Leukemia
      • 6.3.1. Global Targeted Therapeutics Market by Leukemia, 2018–2028(USD Billion)
    • 6.4. Lung Cancer
      • 6.4.1. Global Targeted Therapeutics Market by Lung Cancer, 2018–2028(USD Billion)
    • 6.5. Culorectal Cancer
      • 6.5.1. Global Targeted Therapeutics Market by Culorectal Cancer, 2018–2028(USD Billion)
    • 6.6. Lymphoma
      • 6.6.1. Global Targeted Therapeutics Market by Lymphoma, 2018–2028(USD Billion)
    • 6.7. Renal Cancer
      • 6.7.1. Global Targeted Therapeutics Market by Renal Cancer, 2018–2028(USD Billion)
    • 6.8. Multiple Sclerosis
      • 6.8.1. Global Targeted Therapeutics Market by Multiple Sclerosis, 2018–2028(USD Billion)
    • 6.9. Wet Age-Related Macular Degeneration
      • 6.9.1. Global Targeted Therapeutics Market by Wet Age-Related Macular Degeneration, 2018–2028(USD Billion)
  • Chapter 7. Global Targeted Therapeutics Market– Distribution Channel Analysis
    • 7.1. Global Targeted Therapeutics Market overview: By Distribution Channel
      • 7.1.1. Global Targeted Therapeutics Market share, By Distribution Channel, 2020 and 2028
    • 7.2. Hospital Pharmacies
      • 7.2.1. Global Targeted Therapeutics Market by Hospital Pharmacies, 2018–2028(USD Billion)
    • 7.3. Online Pharmacies
      • 7.3.1. Global Targeted Therapeutics Market by Online Pharmacies, 2018–2028(USD Billion)
    • 7.4. Retail Pharmacies
      • 7.4.1. Global Targeted Therapeutics Market by Retail Pharmacies, 2018–2028(USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Amgen, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Sanofi
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. AstraZeneca
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Development
    • 8.4. Roche Diagnostics
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Development
    • 8.5. Bayer AG
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Novartis AG
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Merck & Co., Inc.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. Seagen, Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Pfizer, Inc.
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. Takeda Pharmaceutical Company Limited
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development
    • 8.11. GlaxoSmithKline plc
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Product Portfolio
      • 8.11.4. Business Strategy
      • 8.11.5. Recent Development

List of Figures

1. Market research Type
2. Market research methodology
3. Global Targeted Therapeutics Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Targeted Therapeutics Marketattractiveness, By Type
6. Global Targeted Therapeutics Marketattractiveness, By Application
7. Global Targeted Therapeutics Marketattractiveness, By Distribution Channel
8. Global Targeted Therapeutics Marketshare by Type ,2020 and 2028 (USD Billion)
9. Global Targeted Therapeutics Marketby Monoclonal Antibodies, 2018–2028(USD Billion)
10. Global Targeted Therapeutics Marketby Small Molecular Inhibitors, 2018–2028(USD Billion)
11. Global Targeted Therapeutics Marketby Prodrug, 2018–2028(USD Billion)
12. Global Targeted Therapeutics Marketby Nano-Particulate Antibody Conjugates, 2018–2028(USD Billion)
13. Global Targeted Therapeutics Marketshare by Application ,2020 and 2028 (USD Billion)
14. Global Targeted Therapeutics Marketby Breast Cancer , 2018–2028(USD Billion)
15. Global Targeted Therapeutics Marketby Leukemia, 2018–2028(USD Billion)
16. Global Targeted Therapeutics Marketby Lung Cancer, 2018–2028(USD Billion)
17. Global Targeted Therapeutics Marketby Colorectal Cancer, 2018–2028(USD Billion)
18. Global Targeted Therapeutics Marketby Lymphoma,  2018–2028(USD Billion)
19. Global Targeted Therapeutics Marketby Renal Cancer, 2018–2028(USD Billion)
20. Global Targeted Therapeutics Marketby Multiple Sclerosis, 2018–2028(USD Billion)
21. Global Targeted Therapeutics Marketby Wet Age-Related Macular Degeneration, 2018–2028(USD Billion)
22. Global Targeted Therapeutics Marketshare by Distribution Channel ,2020 and 2028 (USD Billion)
23. Global Targeted Therapeutics Marketby Hospital Pharmacies , 2018–2028(USD Billion)
24. Global Targeted Therapeutics Marketby Online Pharmacies, 2018–2028(USD Billion)
25. Global Targeted Therapeutics Marketby Retail Pharmacies, 2018–2028(USD Billion)
26. Global Targeted Therapeutics Marketshare, by Region, 2020 and 2028
27. North America Targeted Therapeutics Market, 2018–2028(USD Billion)
28. Europe Targeted Therapeutics Market, 2018–2028(USD Billion)
29. Asia Pacific Targeted Therapeutics Market, 2018–2028(USD Billion)
30. Latin America Targeted Therapeutics Market, 2018–2028(USD Billion)
31. The Middle East and Africa Targeted Therapeutics Market, 2018–2028(USD Billion)
 


List of Tables

1. Global Targeted Therapeutics Market: snapshot
2. Drivers of the Targeted Therapeutics Market: impact analysis
3. North America Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
4. North America Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
5. North America Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
6. The U.S. Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
7. The U.S. Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
8. The U.S. Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
9. Rest of North America Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
10. Rest of North America Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
11. Rest of North America Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
12. Europe Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
13. Europe Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
14. Europe Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
15. UK Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
16. UK Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
17. UK Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
18. France Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
19. France Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
20. France Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
21. Germany Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
22. Germany Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
23. Germany Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
24. Rest of Europe Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
25. Rest of Europe Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
26. Rest of Europe Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
27. Asia Pacific Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
28. Asia Pacific Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
29. Asia Pacific Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
30. China Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
31. China Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
32. China Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
33. Japan Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
34. Japan Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
35. Japan Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
36. India Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
37. India Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
38. India Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
39. Rest of Asia Pacific Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
40. Rest of Asia Pacific Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
41. Rest of Asia Pacific Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
42. Latin America Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
43. Latin America Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
44. Latin America Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
45. Brazil Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
46. Brazil Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
47. Brazil Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
48. Rest of Latin America Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
49. Rest of Latin  America Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
50. Rest of Latin America Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
51. The Middle East and Africa Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
52. The Middle East and Africa Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
53. The Middle east and Africa Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
54. Saudi Arabia Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
55. Saudi Arabia Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
56. Saudi Arabia Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
57. South Africa Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
58. South Africa Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
59. South Africa Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
60. Rest of the Middle East & Africa Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
61. Rest of the Middle East & Africa Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
62. Rest of the Middle East & Africa Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)

 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

High focus on cancer drug development and cytotoxic & non-specific chemotherapies has shifted to molecularly targeted and rationally developed medicines which has potential of providing more efficiency with lesser side-effects. This, in turn, will prompt growth of targeted therapeutics market in coming decade. Necessity for developing specific cancer drugs for treating individuals and requirement of comprehensively understanding genetics & biology of patient will bolster targeted therapeutics market trends. Apart from this, shift towards integrated cancer research activities and highlight on biomarker-based & hypothesis-driven clinical trials is expected to generate lucrative growth avenues for targeted therapeutics market in foreseeable future. Additionally, some of drawbacks of chemotherapy are drug resistance & severe side effects on patients. Moreover, way to reduce the chemotherapy effects on healthy cancer tissues of patients is to alter bio-distribution of medicine and this can be achieved through passive targeting & active targeting of drugs, thereby spearheading business space.

In addition to this, targeted therapeutics is gaining significance owing to its specificity towards cancerous tissues while sparing toxicity to normal as well as off-target cell tissues. In-depth knowledge of molecular activities underlying cancer in human beings and development of new medicines targeting cancerous cells is anticipated to expedite growth of targeted therapeutics industry over upcoming years.

  

According to Zion market research report, the global Targeted Therapeutics market accrued earnings worth approximately 68.1 (USD Billion) in 2020 and is predicted to gain revenue of about 99.3(USD Billion) by 2028, is set to record a CAGR of nearly 12.1% over the period from 2021 to 2028.

Asia Pacific will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to China possessing huge potential due to success of I-PASS clinical trials on patients in the country. Apart from this, China is set to play a key role in production of new anti-cancer therapeutic agents, thereby contributing humungously towards regional market growth. Furthermore, breakthroughs in pharmacokinetics, cancer biology, and pharmacodynamics along with development of core capabilities in molecular testing of tumor samples will create new growth opportunities for targeted therapeutics market in Asia Pacific.

    

The key market participants include Amgen, Inc., Sanofi, AstraZeneca, Roche Diagnostics, Bayer AG, Novartis AG, Merck & Co., Inc., Seagen, Inc., Pfizer, Inc., Takeda Pharmaceutical Company Limited, and GlaxoSmithKline plc.

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social